A detailed history of Nkcfo LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Nkcfo LLC holds 590 shares of LNTH stock, worth $52,681. This represents 0.03% of its overall portfolio holdings.

Number of Shares
590
Previous 590 -0.0%
Holding current value
$52,681
Previous $47,000 38.3%
% of portfolio
0.03%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$58.87 - $83.05 $34,733 - $48,999
590 New
590 $47,000
Q3 2023

Nov 07, 2023

BUY
$60.27 - $90.75 $391,755 - $589,875
6,500 New
6,500 $452,000
Q3 2019

Oct 31, 2019

SELL
$21.01 - $28.94 $176,484 - $243,096
-8,400 Closed
0 $0
Q1 2019

Apr 18, 2019

BUY
$14.93 - $25.1 $125,412 - $210,840
8,400 New
8,400 $206,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.14B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Nkcfo LLC Portfolio

Follow Nkcfo LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nkcfo LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nkcfo LLC with notifications on news.